Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Boyd Steven | 10% Owner | 27 | $207.4K | $1.93M | 2019-01-10 |
| Armistice Capital Master Fund Ltd. | 10% Owner | 45 | $2.39M | $0 | 2018-06-28 |
| SAMANT VIJAY B | President & CEO | 63 | $544.2K | $202.6K | 2018-06-18 |
| Beleson Richard M | Director | 9 | $70 | $0 | 2018-05-23 |
| SHENK THOMAS E | Director | 5 | $0 | $0 | 2018-05-23 |
| MERTON ROBERT C | Director | 20 | $189.2K | $18.5K | 2018-05-23 |
| DOUGLAS R GORDON | Director | 13 | $44.6K | $24.1K | 2018-05-23 |
| LYONS GARY A | Director | 13 | $31.2K | $16.3K | 2018-05-23 |
| MORROW GEORGE J | Director | 11 | $123 | $0 | 2018-05-23 |
| Mammen Mammen | Sr VP, Clinical Development | 3 | $0 | $0 | 2018-01-08 |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | 33 | $127.8K | $43.1K | 2018-01-08 |
| Ramos Anthony Alan | VP, Chief Financial Officer | 43 | $99.7K | $38.6K | 2018-01-08 |
| BILINSKY IGOR | Sr VP, Corporate Development | 16 | $127.8K | $23.6K | 2015-07-13 |
| SHERWIN STEPHEN A | Director | 6 | $70 | $0 | 2015-05-21 |
| SINGER JAMES R | 10% Owner | 53 | $12.02M | $2.28M | 2013-09-12 |
| ROLLAND ALAIN P PHD | Exec VP, Product Development | 30 | $491 | $0 | 2013-08-22 |
| Broadfoot Jill Marie | Sr Vice President, CFO, Sec | 8 | $541 | $0 | 2013-04-01 |
| CAMPBELL ROBERT H | Director | 16 | $73 | $0 | 2012-10-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Boyd Steven | 10% Owner | S Sale | 2019-01-10 | 2019-01-14 | 0 | — | $0 | 2,170,000 | SEC↗ |
| Boyd Steven | 10% Owner | S Sale | 2019-01-10 | 2019-01-14 | 0 | — | $0 | 2,170,000 | SEC↗ |
| Boyd Steven | 10% Owner | S Sale | 2019-01-10 | 2019-01-14 | 2,190,500 | $0.88 | $1.93M | 2,170,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,360,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,360,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 25,606 | $1.21 | $31.0K | 4,360,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,334,394 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,334,394 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,360,500 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 500 | $1.19 | $595 | 4,360,500 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,360,500 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,198,794 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 4,198,794 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 135,600 | $1.21 | $164.1K | 4,334,394 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 998,794 | $1.20 | $1.20M | 4,198,794 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 3,200,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 0 | — | $0 | 3,200,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-28 | 2018-07-02 | 116,091 | $1.21 | $140.5K | 3,200,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 2,600 | $1.25 | $3.3K | 3,054,479 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 0 | — | $0 | 3,083,909 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 0 | — | $0 | 3,083,909 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 1,000 | $1.21 | $1.2K | 3,083,909 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 0 | — | $0 | 3,082,909 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 0 | — | $0 | 3,082,909 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 28,430 | $1.23 | $35.0K | 3,082,909 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 0 | — | $0 | 3,054,479 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-27 | 2018-06-27 | 0 | — | $0 | 3,054,479 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-26 | 2018-06-27 | 0 | — | $0 | 3,051,879 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-26 | 2018-06-27 | 0 | — | $0 | 3,051,879 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-26 | 2018-06-27 | 9,103 | $1.24 | $11.3K | 3,051,879 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 3,042,776 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 3,042,776 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-06-25 | 2018-06-27 | 10,672 | $1.26 | $13.4K | 3,042,776 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-22 | 2018-06-22 | 14,520 | $1.25 | $18.1K | 3,032,104 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-22 | 2018-06-22 | 0 | — | $0 | 3,032,104 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-22 | 2018-06-22 | 0 | — | $0 | 3,032,104 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-21 | 2018-06-22 | 0 | — | $0 | 3,017,584 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-21 | 2018-06-22 | 0 | — | $0 | 3,017,584 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-21 | 2018-06-22 | 140 | $1.25 | $175 | 3,017,584 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-20 | 2018-06-22 | 0 | — | $0 | 3,017,444 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-20 | 2018-06-22 | 3,702 | $1.27 | $4.7K | 3,017,444 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-20 | 2018-06-22 | 0 | — | $0 | 3,017,444 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2018-06-18 | 2018-06-19 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-18 | 2018-06-18 | 0 | — | $0 | 3,013,742 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-18 | 2018-06-18 | 0 | — | $0 | 3,013,742 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-18 | 2018-06-18 | 13,742 | $1.20 | $16.5K | 3,013,742 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-14 | 2018-06-18 | 0 | — | $0 | 3,000,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-14 | 2018-06-18 | 0 | — | $0 | 3,000,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-14 | 2018-06-18 | 29,103 | $1.15 | $33.5K | 3,000,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-13 | 2018-06-13 | 145,297 | $1.07 | $155.5K | 2,970,897 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-13 | 2018-06-13 | 0 | — | $0 | 2,970,897 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-13 | 2018-06-13 | 0 | — | $0 | 2,970,897 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-12 | 2018-06-13 | 0 | — | $0 | 2,800,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-12 | 2018-06-13 | 0 | — | $0 | 2,800,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-12 | 2018-06-13 | 131,295 | $1.23 | $161.5K | 2,800,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-12 | 2018-06-13 | 25,600 | $1.08 | $27.6K | 2,825,600 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-12 | 2018-06-13 | 0 | — | $0 | 2,825,600 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-12 | 2018-06-13 | 0 | — | $0 | 2,825,600 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-11 | 2018-06-13 | 0 | — | $0 | 2,668,705 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-11 | 2018-06-13 | 0 | — | $0 | 2,668,705 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-11 | 2018-06-13 | 68,705 | $1.21 | $83.1K | 2,668,705 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-11 | 2018-06-13 | 0 | — | $0 | 2,600,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-11 | 2018-06-13 | 0 | — | $0 | 2,600,000 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | P Buy | 2018-06-11 | 2018-06-13 | 300,000 | $1.18 | $354.0K | 2,600,000 | SEC↗ |
| SHENK THOMAS E | Director | A Award deriv | 2018-05-23 | 2018-05-24 | 6,500 | — | $0 | 6,500 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award deriv | 2018-05-23 | 2018-05-24 | 8,000 | — | $0 | 8,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2018-05-23 | 2018-05-24 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MORROW GEORGE J | Director | A Award deriv | 2018-05-23 | 2018-05-24 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Beleson Richard M | Director | A Award deriv | 2018-05-23 | 2018-05-24 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MERTON ROBERT C | Director | A Award deriv | 2018-05-23 | 2018-05-24 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 0 | — | $0 | 2,280,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 35,000 | $1.42 | $49.7K | 2,235,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 0 | — | $0 | 2,235,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 0 | — | $0 | 2,300,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 0 | — | $0 | 2,300,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 20,000 | $1.46 | $29.2K | 2,300,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 0 | — | $0 | 2,280,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 45,000 | $1.43 | $64.3K | 2,280,000 | SEC↗ |
| Boyd Steven | 10% Owner | P Buy | 2018-01-22 | 2018-01-26 | 0 | — | $0 | 2,235,000 | SEC↗ |
| SMITH LAWRENCE RUSSELL | Sr VP, Research | A Award deriv | 2018-01-08 | 2018-01-10 | 8,467 | — | $0 | 8,467 | SEC↗ |
| SMITH LAWRENCE RUSSELL | Sr VP, Research | A Award deriv | 2018-01-08 | 2018-01-10 | 51,533 | — | $0 | 51,533 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Financial Officer | A Award deriv | 2018-01-08 | 2018-01-10 | 14,562 | — | $0 | 14,562 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Financial Officer | A Award deriv | 2018-01-08 | 2018-01-10 | 55,438 | — | $0 | 55,438 | SEC↗ |
| Mammen Mammen | Sr VP, Clinical Development | A Award deriv | 2018-01-08 | 2018-01-10 | 57,158 | — | $0 | 57,158 | SEC↗ |
| Mammen Mammen | Sr VP, Clinical Development | A Award deriv | 2018-01-08 | 2018-01-10 | 12,842 | — | $0 | 12,842 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2018-01-08 | 2018-01-10 | 36,775 | — | $0 | 36,775 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2018-01-08 | 2018-01-10 | 68,225 | — | $0 | 68,225 | SEC↗ |
| MERTON ROBERT C | Director | P Buy | 2017-11-10 | 2017-11-14 | 85,700 | $1.75 | $150.0K | 95,451 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2017-05-25 | 2017-05-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SMITH LAWRENCE RUSSELL | Sr VP, Research | A Award deriv | 2017-05-25 | 2017-05-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Financial Officer | A Award deriv | 2017-05-25 | 2017-05-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2017-05-25 | 2017-05-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MERTON ROBERT C | Director | A Award deriv | 2017-05-25 | 2017-05-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MORROW GEORGE J | Director | A Award deriv | 2017-05-25 | 2017-05-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Beleson Richard M | Director | A Award deriv | 2017-05-25 | 2017-05-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Mammen Mammen | Sr VP, Clinical Development | A Award deriv | 2017-05-25 | 2017-05-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award deriv | 2017-05-25 | 2017-05-30 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SHENK THOMAS E | Director | A Award deriv | 2017-05-25 | 2017-05-31 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2017-03-27 | 2017-03-28 | 4,250 | $2.17 | $9.2K | 9,674 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2017-03-15 | 2017-03-17 | 875 | $2.31 | $2.0K | 17,696 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2017-02-10 | 2017-02-14 | 4,500 | $2.26 | $10.2K | 18,571 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2017-02-01 | 2017-02-03 | 3,750 | $2.16 | $8.1K | 87,420 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award deriv | 2017-01-12 | 2017-01-17 | 787 | — | $0 | 20,000 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award deriv | 2017-01-12 | 2017-01-17 | 19,213 | — | $0 | 19,213 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award deriv | 2017-01-12 | 2017-01-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2017-01-12 | 2017-01-17 | 18,823 | — | $0 | 18,823 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2017-01-12 | 2017-01-17 | 1,177 | — | $0 | 20,000 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2017-01-12 | 2017-01-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2017-01-12 | 2017-01-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2017-01-12 | 2017-01-17 | 28,146 | — | $0 | 28,146 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2017-01-12 | 2017-01-17 | 21,854 | — | $0 | 50,000 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2017-01-11 | 2017-01-13 | 54 | $2.48 | $134 | 23,071 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2017-01-10 | 2017-01-12 | 5,763 | $2.45 | $14.1K | 91,170 | SEC↗ |
| MERTON ROBERT C | Director | S Sale | 2016-12-22 | 2016-12-22 | 2,000 | $2.26 | $4.5K | 9,751 | SEC↗ |
| MERTON ROBERT C | Director | S Sale | 2016-12-21 | 2016-12-22 | 2,000 | $2.22 | $4.4K | 11,751 | SEC↗ |
| MERTON ROBERT C | Director | S Sale | 2016-12-20 | 2016-12-20 | 2,000 | $2.22 | $4.4K | 13,751 | SEC↗ |
| MERTON ROBERT C | Director | S Sale | 2016-12-19 | 2016-12-20 | 2,327 | $2.21 | $5.1K | 15,751 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-12-13 | 2016-12-13 | 4,649 | $2.40 | $11.2K | 96,933 | SEC↗ |
| DOUGLAS R GORDON | Director | S Sale | 2016-12-12 | 2016-12-13 | 10,078 | $2.39 | $24.1K | 10,828 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-12-12 | 2016-12-13 | 11,050 | $2.39 | $26.4K | 101,582 | SEC↗ |
| LYONS GARY A | Director | S Sale | 2016-12-05 | 2016-12-07 | 7,078 | $2.30 | $16.3K | 7,828 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2016-10-11 | 2016-10-12 | 54 | $3.05 | $165 | 23,125 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2016-07-11 | 2016-07-13 | 54 | $4.46 | $241 | 23,179 | SEC↗ |
| MERTON ROBERT C | Director | P Buy | 2016-06-14 | 2016-06-14 | 4,100 | $4.41 | $18.1K | 18,078 | SEC↗ |
| MERTON ROBERT C | Director | P Buy | 2016-06-13 | 2016-06-14 | 4,900 | $4.29 | $21.0K | 13,978 | SEC↗ |
| SAMANT VIJAY B | President & CEO | P Buy | 2016-06-09 | 2016-06-10 | 15,700 | $4.72 | $74.1K | 112,632 | SEC↗ |
| DOUGLAS R GORDON | Director | P Buy | 2016-06-06 | 2016-06-08 | 10,078 | $4.41 | $44.4K | 20,906 | SEC↗ |
| LYONS GARY A | Director | P Buy | 2016-06-03 | 2016-06-06 | 7,078 | $4.39 | $31.1K | 14,906 | SEC↗ |
| SHENK THOMAS E | Director | A Award deriv | 2016-05-20 | 2016-05-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Beleson Richard M | Director | A Award deriv | 2016-05-20 | 2016-05-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MERTON ROBERT C | Director | A Award deriv | 2016-05-20 | 2016-05-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MORROW GEORGE J | Director | A Award deriv | 2016-05-20 | 2016-05-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2016-05-20 | 2016-05-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award deriv | 2016-05-20 | 2016-05-24 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2016-05-20 | 2016-05-24 | 212,500 | — | $0 | 212,500 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2016-03-15 | 2016-03-17 | 8,750 | $0.41 | $3.6K | 232,331 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-03-03 | 2016-03-03 | 5,900 | $0.37 | $2.2K | 969,326 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-03-02 | 2016-03-03 | 14,000 | $0.37 | $5.2K | 975,226 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-03-01 | 2016-03-03 | 17,600 | $0.35 | $6.2K | 989,226 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2016-02-19 | 2016-02-22 | 7,500 | $0.33 | $2.5K | 139,235 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2016-01-25 | 2016-01-26 | 193 | $0.35 | $68 | 146,735 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2016-01-15 | 2016-01-15 | 20,071 | — | $0 | 250,000 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2016-01-15 | 2016-01-15 | 229,929 | — | $0 | 229,929 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award deriv | 2016-01-15 | 2016-01-15 | 67,888 | — | $0 | 300,000 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award deriv | 2016-01-15 | 2016-01-15 | 232,112 | — | $0 | 232,112 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2016-01-15 | 2016-01-15 | 199,244 | — | $0 | 425,000 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2016-01-15 | 2016-01-15 | 225,756 | — | $0 | 225,756 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-01-12 | 2016-01-13 | 11,202 | $0.35 | $3.9K | 1,006,826 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2016-01-11 | 2016-01-13 | 974 | $0.36 | $351 | 241,081 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-01-11 | 2016-01-13 | 48,535 | $0.35 | $17.0K | 1,018,028 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2016-01-07 | 2016-01-08 | 75,000 | $0.36 | $27.0K | 1,066,563 | SEC↗ |
| SHENK THOMAS E | Director | A Award deriv | 2015-12-18 | 2015-12-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SHENK THOMAS E | Director | A Award | 2015-12-18 | 2015-12-22 | 10,000 | $0.01 | $100 | 10,000 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2015-10-23 | 2015-10-27 | 193 | $0.39 | $75 | 146,928 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2015-10-12 | 2015-10-14 | 4,738 | $0.41 | $1.9K | 1,141,563 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2015-10-12 | 2015-10-14 | 974 | $0.43 | $419 | 242,055 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2015-07-23 | 2015-07-27 | 194 | $0.62 | $120 | 147,121 | SEC↗ |
| BILINSKY IGOR | Sr VP, Corporate Development | S Sale | 2015-07-13 | 2015-07-15 | 1,258 | $0.70 | $881 | 193,798 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2015-07-13 | 2015-07-15 | 4,737 | $0.70 | $3.3K | 1,146,301 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2015-07-13 | 2015-07-15 | 974 | $0.70 | $682 | 243,029 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2015-05-21 | 2015-05-26 | 125,000 | — | $0 | 125,000 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award deriv | 2015-05-21 | 2015-05-26 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MERTON ROBERT C | Director | A Award deriv | 2015-05-21 | 2015-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2015-05-21 | 2015-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Beleson Richard M | Director | A Award deriv | 2015-05-21 | 2015-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award deriv | 2015-05-21 | 2015-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MORROW GEORGE J | Director | A Award deriv | 2015-05-21 | 2015-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 108,281 | SEC↗ |
| MERTON ROBERT C | Director | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 90,781 | SEC↗ |
| LYONS GARY A | Director | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 78,281 | SEC↗ |
| Beleson Richard M | Director | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 22,078 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 22,003 | SEC↗ |
| MORROW GEORGE J | Director | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 27,347 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2015-04-23 | 2015-04-27 | 193 | $1.01 | $195 | 147,315 | SEC↗ |
| BILINSKY IGOR | Sr VP, Corporate Development | S Sale | 2015-04-13 | 2015-04-15 | 1,257 | $0.93 | $1.2K | 195,056 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2015-04-13 | 2015-04-15 | 974 | $0.93 | $906 | 244,003 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2015-04-13 | 2015-04-15 | 4,738 | $0.93 | $4.4K | 1,151,038 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2015-03-30 | 2015-04-01 | 55,000 | $0.91 | $50.0K | 1,155,776 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2015-01-21 | 2015-01-22 | 428 | $1.09 | $467 | 147,508 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2015-01-19 | 2015-01-21 | 67,500 | — | $0 | 67,500 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2015-01-19 | 2015-01-21 | 52,500 | — | $0 | 120,000 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2015-01-19 | 2015-01-21 | 171,606 | — | $0 | 250,000 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2015-01-19 | 2015-01-21 | 78,394 | — | $0 | 78,394 | SEC↗ |
| BILINSKY IGOR | Sr VP, Corporate Development | A Award deriv | 2015-01-19 | 2015-01-21 | 61,249 | — | $0 | 140,000 | SEC↗ |
| BILINSKY IGOR | Sr VP, Corporate Development | A Award deriv | 2015-01-19 | 2015-01-21 | 78,751 | — | $0 | 78,751 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award deriv | 2015-01-19 | 2015-01-21 | 43,750 | — | $0 | 100,000 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award deriv | 2015-01-19 | 2015-01-21 | 56,250 | — | $0 | 56,250 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award | 2015-01-19 | 2015-01-21 | 70,000 | $0.01 | $700 | 244,977 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award | 2015-01-19 | 2015-01-21 | 300,000 | $0.01 | $3.0K | 1,210,776 | SEC↗ |
| BILINSKY IGOR | Sr VP, Corporate Development | A Award | 2015-01-19 | 2015-01-21 | 70,000 | $0.01 | $700 | 196,313 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | A Award | 2015-01-19 | 2015-01-21 | 60,000 | $0.01 | $600 | 147,936 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2015-01-13 | 2015-01-14 | 4,737 | $1.12 | $5.3K | 910,776 | SEC↗ |
| BILINSKY IGOR | Sr VP, Corporate Development | S Sale | 2015-01-12 | 2015-01-14 | 1,335 | $1.16 | $1.5K | 126,313 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2015-01-12 | 2015-01-14 | 1,912 | $1.16 | $2.2K | 174,977 | SEC↗ |
| SAMANT VIJAY B | President & CEO | G Gift | 2014-12-26 | 2014-12-29 | 5,300 | — | $0 | 915,513 | SEC↗ |
| SAMANT VIJAY B | President & CEO | G Gift | 2014-12-23 | 2014-12-23 | 321 | — | $0 | 920,813 | SEC↗ |
| SAMANT VIJAY B | President & CEO | G Gift | 2014-12-22 | 2014-12-23 | 15,379 | — | $0 | 921,134 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2014-12-18 | 2014-12-18 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2014-10-21 | 2014-10-22 | 428 | $1.18 | $505 | 87,936 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2014-10-13 | 2014-10-14 | 1,912 | $1.08 | $2.1K | 176,889 | SEC↗ |
| BILINSKY IGOR | Sr VP, Corporate Development | S Sale | 2014-10-13 | 2014-10-14 | 1,335 | $1.08 | $1.4K | 127,648 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2014-10-13 | 2014-10-14 | 4,738 | $1.13 | $5.4K | 936,513 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2014-08-26 | 2014-08-27 | 12,500 | $1.25 | $15.6K | 88,364 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2014-08-26 | 2014-08-27 | 12,500 | $1.25 | $15.6K | 178,801 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | S Sale | 2014-08-26 | 2014-08-27 | 12,500 | $1.25 | $15.6K | 128,983 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2014-07-21 | 2014-07-21 | 428 | $1.29 | $552 | 100,864 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2014-07-14 | 2014-07-15 | 4,737 | $1.17 | $5.5K | 941,251 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2014-07-11 | 2014-07-15 | 1,912 | $1.16 | $2.2K | 191,301 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | S Sale | 2014-07-11 | 2014-07-15 | 1,335 | $1.16 | $1.5K | 141,483 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award deriv | 2014-05-22 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MORROW GEORGE J | Director | A Award deriv | 2014-05-22 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MERTON ROBERT C | Director | A Award deriv | 2014-05-22 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2014-05-22 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Beleson Richard M | Director | A Award deriv | 2014-05-22 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award deriv | 2014-05-22 | 2014-05-23 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 14,503 | SEC↗ |
| MORROW GEORGE J | Director | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 19,847 | SEC↗ |
| MERTON ROBERT C | Director | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 83,281 | SEC↗ |
| LYONS GARY A | Director | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 70,781 | SEC↗ |
| Beleson Richard M | Director | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 14,578 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 100,781 | SEC↗ |
| Ramos Anthony Alan | VP, Chief Accounting Officer | S Sale | 2014-04-21 | 2014-04-21 | 428 | $1.22 | $522 | 101,292 | SEC↗ |
| SAMANT VIJAY B | President & CEO | S Sale | 2014-04-14 | 2014-04-15 | 4,738 | $1.16 | $5.5K | 945,988 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | S Sale | 2014-04-11 | 2014-04-14 | 1,150 | $1.21 | $1.4K | 142,818 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | S Sale | 2014-04-11 | 2014-04-14 | 1,912 | $1.21 | $2.3K | 193,213 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2014-01-24 | 2014-01-27 | 209 | $1.49 | $311 | 101,720 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2014-01-23 | 2014-01-27 | 82 | $1.59 | $130 | 101,929 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2014-01-21 | 2014-01-22 | 164 | $1.66 | $272 | 102,011 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2014-01-19 | 2014-01-22 | 164 | $1.66 | $272 | 102,175 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | F Tax w/h | 2014-01-13 | 2014-01-14 | 305 | $1.34 | $409 | 143,968 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | F Tax w/h | 2014-01-13 | 2014-01-14 | 305 | $1.34 | $409 | 195,125 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2014-01-13 | 2014-01-14 | 1,464 | $1.34 | $2.0K | 950,726 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | F Tax w/h | 2014-01-11 | 2014-01-14 | 1,419 | $1.42 | $2.0K | 144,273 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | F Tax w/h | 2014-01-11 | 2014-01-14 | 1,501 | $1.42 | $2.1K | 195,430 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | F Tax w/h | 2014-01-11 | 2014-01-14 | 491 | $1.42 | $697 | 196,931 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2014-01-11 | 2014-01-14 | 2,623 | $1.42 | $3.7K | 959,588 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2014-01-11 | 2014-01-14 | 7,398 | $1.42 | $10.5K | 952,190 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | A Award deriv | 2014-01-10 | 2014-01-14 | 135,000 | — | $0 | 540,826 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award deriv | 2014-01-10 | 2014-01-14 | 135,000 | — | $0 | 717,850 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | A Award deriv | 2014-01-10 | 2014-01-14 | 2 | — | $0 | 359,602 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | A Award deriv | 2014-01-10 | 2014-01-14 | 99,998 | — | $0 | 459,600 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award deriv | 2014-01-10 | 2014-01-14 | 500,000 | — | $0 | 2,809,000 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | P Buy | 2014-01-10 | 2014-01-14 | 90,000 | $1.42 | $127.8K | 145,692 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | P Buy | 2014-01-10 | 2014-01-14 | 90,000 | $1.42 | $127.8K | 197,422 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | P Buy | 2014-01-10 | 2014-01-14 | 70,000 | $1.42 | $99.4K | 102,339 | SEC↗ |
| SAMANT VIJAY B | President & CEO | P Buy | 2014-01-10 | 2014-01-14 | 330,000 | $1.42 | $468.6K | 962,211 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | A Award | 2014-01-10 | 2014-01-15 | 70,000 | $0.01 | $700 | 102,339 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | A Award | 2014-01-10 | 2014-01-15 | 90,000 | $0.01 | $900 | 143,968 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | A Award | 2014-01-10 | 2014-01-15 | 90,000 | $0.01 | $900 | 195,125 | SEC↗ |
| SAMANT VIJAY B | President & CEO | A Award | 2014-01-10 | 2014-01-15 | 330,000 | $0.01 | $3.3K | 950,726 | SEC↗ |
| SMITH LAWRENCE RUSSELL | VP, Vaccine Research | F Tax w/h | 2014-01-07 | 2014-01-08 | 655 | $1.31 | $858 | 107,422 | SEC↗ |
| BILINSKY IGOR | Senior VP, Corporate Dev't | F Tax w/h | 2014-01-07 | 2014-01-08 | 54 | $1.31 | $71 | 55,692 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | S Sale | 2013-11-12 | 2013-11-14 | 7,918 | $1.11 | $8.8K | 32,339 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-10-23 | 2013-10-24 | 82 | $1.49 | $122 | 40,257 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-10-21 | 2013-10-21 | 163 | $1.36 | $222 | 40,339 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-10-19 | 2013-10-21 | 163 | $1.34 | $218 | 40,502 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2013-10-13 | 2013-10-15 | 1,463 | $1.29 | $1.9K | 632,211 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2013-10-11 | 2013-10-11 | 2,621 | $1.29 | $3.4K | 633,674 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-09-12 | 2013-09-12 | 200,000 | $1.29 | $258.0K | 8,670,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-09-11 | 2013-09-12 | 300,000 | $1.30 | $390.0K | 8,870,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-09-10 | 2013-09-12 | 200,000 | $1.23 | $246.0K | 9,170,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-09-09 | 2013-09-10 | 200,000 | $1.22 | $244.0K | 9,370,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-09-04 | 2013-09-04 | 216,000 | $1.22 | $263.5K | 9,570,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-09-03 | 2013-09-04 | 250,000 | $1.26 | $315.0K | 9,786,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-08-30 | 2013-09-03 | 84,000 | $1.31 | $110.0K | 10,036,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-08-29 | 2013-08-30 | 150,000 | $1.30 | $195.0K | 10,120,000 | SEC↗ |
| SINGER JAMES R | 10% Owner | S Sale | 2013-08-28 | 2013-08-30 | 200,000 | $1.31 | $262.0K | 10,270,000 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | A Award deriv | 2013-08-26 | 2013-08-27 | 150,000 | — | $0 | 359,600 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | P Buy | 2013-08-26 | 2013-08-27 | 25,000 | $0.01 | $250 | 40,665 | SEC↗ |
| ROLLAND ALAIN P PHD | Exec VP, Product Development | F Tax w/h | 2013-08-22 | 2013-08-23 | 13,527 | $1.33 | $18.0K | 127,583 | SEC↗ |
| SAMANT VIJAY B | President & CEO | G Gift | 2013-08-05 | 2013-08-07 | 1,400 | — | $0 | 636,295 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-07-23 | 2013-07-24 | 83 | $3.35 | $278 | 15,665 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-07-21 | 2013-07-22 | 164 | $3.62 | $594 | 15,748 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-07-19 | 2013-07-22 | 164 | $3.62 | $594 | 15,912 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2013-07-13 | 2013-07-15 | 1,471 | $3.73 | $5.5K | 637,695 | SEC↗ |
| ROLLAND ALAIN P PHD | Exec VP, Product Development | F Tax w/h | 2013-07-13 | 2013-07-15 | 592 | $3.73 | $2.2K | 172,542 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2013-07-11 | 2013-07-15 | 2,635 | $3.72 | $9.8K | 639,166 | SEC↗ |
| ROLLAND ALAIN P PHD | Exec VP, Product Development | F Tax w/h | 2013-07-11 | 2013-07-15 | 1,097 | $3.72 | $4.1K | 173,134 | SEC↗ |
| ROLLAND ALAIN P PHD | Exec VP, Product Development | F Tax w/h | 2013-07-07 | 2013-07-08 | 1,317 | $3.61 | $4.8K | 174,231 | SEC↗ |
| MERTON ROBERT C | Director | A Award deriv | 2013-05-23 | 2013-05-28 | 39,619 | — | $0 | 298,741 | SEC↗ |
| DOUGLAS R GORDON | Director | A Award deriv | 2013-05-23 | 2013-05-28 | 52,048 | — | $0 | 453,296 | SEC↗ |
| MORROW GEORGE J | Director | A Award deriv | 2013-05-23 | 2013-05-28 | 39,619 | — | $0 | 75,894 | SEC↗ |
| Beleson Richard M | Director | A Award deriv | 2013-05-23 | 2013-05-28 | 40,176 | — | $0 | 40,176 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2013-05-23 | 2013-05-28 | 39,619 | — | $0 | 284,678 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award deriv | 2013-05-23 | 2013-05-28 | 40,176 | — | $0 | 40,176 | SEC↗ |
| MERTON ROBERT C | Director | P Buy | 2013-05-23 | 2013-05-28 | 5,953 | $0.01 | $60 | 75,781 | SEC↗ |
| DOUGLAS R GORDON | Director | P Buy | 2013-05-23 | 2013-05-28 | 5,953 | $0.01 | $60 | 93,281 | SEC↗ |
| MORROW GEORGE J | Director | P Buy | 2013-05-23 | 2013-05-28 | 5,953 | $0.01 | $60 | 12,347 | SEC↗ |
| Beleson Richard M | Director | P Buy | 2013-05-23 | 2013-05-28 | 7,003 | $0.01 | $70 | 7,078 | SEC↗ |
| LYONS GARY A | Director | P Buy | 2013-05-23 | 2013-05-28 | 5,953 | $0.01 | $60 | 63,281 | SEC↗ |
| SHERWIN STEPHEN A | Director | P Buy | 2013-05-23 | 2013-05-28 | 7,003 | $0.01 | $70 | 7,003 | SEC↗ |
| MERTON ROBERT C | Director | M Exercise deriv | 2013-05-10 | 2013-05-13 | 12,500 | — | $0 | 259,122 | SEC↗ |
| MERTON ROBERT C | Director | M Exercise | 2013-05-10 | 2013-05-13 | 12,500 | $3.59 | $44.9K | 69,828 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-04-23 | 2013-05-31 | 82 | $3.63 | $298 | 16,076 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-04-21 | 2013-05-31 | 164 | $3.81 | $625 | 16,158 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | F Tax w/h | 2013-04-19 | 2013-05-31 | 164 | $3.81 | $625 | 16,322 | SEC↗ |
| Ramos Anthony Alan | Chief Accounting Officer | A Award deriv | 2013-04-16 | 2013-04-18 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ROLLAND ALAIN P PHD | Exec VP, Product Development | F Tax w/h | 2013-04-13 | 2013-04-15 | 593 | $4.13 | $2.4K | 175,548 | SEC↗ |
| SAMANT VIJAY B | President & CEO | F Tax w/h | 2013-04-13 | 2013-04-15 | 1,471 | $4.13 | $6.1K | 641,801 | SEC↗ |
| ROLLAND ALAIN P PHD | Exec VP, Product Development | F Tax w/h | 2013-04-11 | 2013-04-15 | 1,098 | $4.10 | $4.5K | 176,141 | SEC↗ |